Promimic AB (publ) (STO:PRO)
Sweden · Delayed Price · Currency is SEK 13.80
-0.20 (-1.43%)
Nov 4, 2025, 2:40 PM CET
Promimic AB Revenue
Promimic AB had revenue of 13.17M SEK in the quarter ending June 30, 2025, with 2.35% growth. This brings the company's revenue in the last twelve months to 50.24M, up 14.88% year-over-year. In the year 2024, Promimic AB had annual revenue of 48.91M with 24.73% growth.
Revenue (ttm)
50.24M
Revenue Growth
+14.88%
P/S Ratio
5.19
Revenue / Employee
2.79M
Employees
19
Market Cap
260.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 48.91M | 9.70M | 24.73% |
| Dec 31, 2023 | 39.21M | 22.14M | 129.65% |
| Dec 31, 2022 | 17.07M | 9.01M | 111.65% |
| Dec 31, 2021 | 8.07M | 2.46M | 43.80% |
| Dec 31, 2020 | 5.61M | -132.62K | -2.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |